Atlas Trials

Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer

Clinical trial NCT03577743 · COMPLETED

Trial details

NCT number
NCT03577743
Sponsor
Assiut University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Triple Negative Breast CancerSafety IssuesEfficacy
Start date
2018-07-01
Primary completion
2020-03-15
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.